ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*J2.0.21 - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification201502022536422CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120230621W173deBibliographieenBibliographyfrBibliographieEP12703408.0201202012012091820130705enenen201161438780 P20110202US2023062120232520121226201252201404302014182013112820140430AL20140730BG20140430CY20140430CZ20140430EE20140430FI20140430HR20140830IS20140430LT20150201LU20140430LV20140430MC20140430MK20140430MT20140730NO20140430RO20140430RS20140430SI20140430SK20140430SM20230621202325A61K 38/08 20060101AFI20131107BHEP A61P 17/02 20060101ALI20131107BHEP A61K 38/085 20130101 FI20130101BHEP A61P 17/00 20180101 LI20200319BHEP A61P 17/02 20180101 LI20200319BHEP A61P 43/00 20180101 LI20200331BHEP A61P 3/10 20180101 LI20200331BHEP deVERFAHREN ZUR BEHANDLUNG VON DIABETISCHEN FUSSGESCHWÜRENenMETHODS FOR TREATING DIABETIC FOOT ULCERSfrPROCÉDÉS DE TRAITEMENT D'ULCÈRES DU PIED DIABÉTIQUEWO-A1-2011/120032RODGERS K E ET AL: "Fragments of Nle3-angiotensin(1-7) accelerate healing in dermal models", JOURNAL OF PEPTIDE RESEARCH, BLACKWELL PUBLISHING LTD, OXFORD; GB, vol. 66, no. SUPPL. 1, 1 December 2005 (2005-12-01), pages 41-47, XP002643256, ISSN: 1397-002XRODGERS K E ET AL: "ACCELERATION OF HEALING, REDUCTION OF FIBROTIC SCAR, AND NORMALIZATION OF TISSUE ARCHITECTURE BY AN ANGIOTENSIN ANALOGUE, NORLEU3-A(1-7)", PLASTIC AND RECONSTRUCTIVE SURGERY, WILLIAMS AND WILKINS CO., BALTIMORE, MD, US, vol. 111, no. 3, 1 March 2003 (2003-03-01) , pages 1195-1206, XP008059840, ISSN: 0032-1052, DOI: 10.1097/01.PRS.0000047403.23105.66KATHLEEN E. RODGERS ET AL: "Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice", EXPERIMENTAL DERMATOLOGY, vol. 12, no. 6, 1 December 2003 (2003-12-01), pages 784-790, XP55032955, ISSN: 0906-6705, DOI: 10.1111/j.0906-6705.2003.00087.xUS-NIH: "Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers", , 14 May 2010 (2010-05-14), XP002680220, Retrieved from the Internet: URL:http://web.archive.org/web/20100514120 507/http://www.clinicaltrials.gov/ct2/show /NCT00796744? [retrieved on 2012-07-17]MATUSZEWSKA BOZENA ET AL: "Acidic fibroblast growth factor: Evaluation of topical formulations in a diabetic mouse wound healing model", PHARMACEUTICAL RESEARCH (NEW YORK), vol. 11, no. 1, 1994, pages 65-71, XP009161289, ISSN: 0724-8741PETER P. BALINGIT ET AL: "NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: Results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial", WOUND REPAIR AND REGENERATION, 1 July 2012 (2012-07-01), pages N/A-N/A, XP55032963, ISSN: 1067-1927, DOI: 10.1111/j.1524-475X.2012.00804.xCARNEY D H ET AL: "Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair?", EXPERT OPINION ON PHARMACOTHERAPY 200810 GB LNKD- DOI:10.1517/14656566.9.15.2717, vol. 9, no. 15, October 2008 (2008-10), pages 2717-2726, XP009161260, ISSN: 1465-6566RODGERS, Kathleen, E.4403 E. Galeano StreetLong Beach, CA 90815USDIZEREGA, Gere, S.4491 GreenbrierSan Luis Obispo, CA 93401USUniversity of Southern California1013815452045-1-EP3740 McClintock AvenueLos Angeles, CA 90089-2561USEttmayr, Andreaset al100764567KEHL, ASCHERL, LIEBHOFF & ETTMAYR Patentanwälte Emil-Riedel-Strasse 1880538 MünchenDEALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201202348420120201enWO20121064272012080920123220120920000000